Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intradermal Acupuncture as an Adjunct to SSRI Tapering in Major Depressive Disorder
NCT07390981Not yet recruiting
- Sponsor
- Hangzhou First People's Hospital
- Start
- Oct 2026
- Primary completion
- Oct 2028
01
Overview
Randomised trial in major depressive disorder (MDD) (3 arms), sponsored by Hangzhou First People's Hospital. Primary endpoint: Selective Serotonin Reuptake Inhibitor Dose Reduction Rate at 12 weeks. Planned start Oct 2026; status: not yet recruiting.
02
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT07390981.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07390981.